Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study (ICC case series)

被引：0
|
作者：
Biemans, V. [1 ,2 ]
van der Meulen-de Jong, A. [3 ]
van der Woude, C. [4 ]
de Boer, N. [5 ]
Dijkstra, G. [6 ]
Oldenburg, B. [7 ]
Ponsioen, C. [8 ]
Maljaars, P. [3 ]
Haans, J. [2 ]
Pierik, M. [2 ]
Hoentjen, F. [9 ]
机构：
[1] Radboudumc, Nijmegen, Netherlands
[2] MUMC, Maastricht, Netherlands
[3] LUMC, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Inst Educ, Dept Gastroenterol & Hepatol, Room J393, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Groningen, Netherlands
[7] Univ Med Ctr Utrecht, Utrecht, Netherlands
[8] AMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] Radboudumc, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP036
引用
收藏
页码：S55 / S56
页数：3
相关论文
共 50 条
  • [1] USTEKINUMAB FOR CROHN'S DISEASE: A NATIONWIDE REAL-LIFE OBSERVATIONAL COHORT STUDY (ICC CASE SERIES)
    Biemans, Vince
    Van der Meulen, Andrea
    Van der Woude, Christien Janneke
    de Boer, Nanne
    Dijkstra, Gerard
    Oldenburg, Bas
    Ponsioen, Cyriel
    Maljaars, Jeroen
    Haans, Jeoffrey
    Pierik, Marie
    Hoentjen, Frank
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S842 - S843
  • [2] Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
    Biemans, V.
    van der Woude, C.
    van der Meulen-de Jong, A.
    Dijkstra, G.
    de Boer, N.
    Oldenburg, B.
    Ponsioen, C.
    de Vries, A.
    Wintjens, D.
    Hoentjen, F.
    Pierik, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S66 - S67
  • [3] Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland
    Eberl, A.
    Hallinen, T.
    af Bjorkesten, C. -G.
    Heikkinen, M.
    Hirsi, E.
    Kellokumpu, M.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nuutinen, H.
    Suhonen, U. -M.
    Utriainen, K.
    Vihriala, I.
    Soini, E.
    Wennerstrom, C.
    Nissinen, R.
    Borsi, A.
    Koivunen, M.
    Tillonen, J.
    Sipponen, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S415 - S416
  • [4] Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
    Biemans, Vince B. C.
    van der Meulen-de Jong, Andrea E.
    van der Woude, Christine J.
    Lowenberg, Mark
    Dijkstra, Gerard
    Oldenburg, Bas
    de Boer, Nanne K. H.
    van der Marel, Sander
    Bodelier, Alexander G. L.
    Jansen, Jeroen M.
    Haans, Jeoffrey J. L.
    Theeuwen, Rosaline
    de Jong, Dirk
    Pierik, Marie J.
    Hoentjen, Frank
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (01): : 33 - 45
  • [5] Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
    Eberl, Anja
    Hallinen, Taru
    af Bjorkesten, Clas-Goran
    Heikkinen, Markku
    Hirsi, Eija
    Kellokumpu, Mikko
    Koskinen, Inka
    Moilanen, Veikko
    Nielsen, Christian
    Nuutinen, Heikki
    Suhonen, Ulla-Maija
    Utriainen, Karri
    Vihriala, Ilkka
    Soini, Erkki
    Wennerstrom, Christina
    Nissinen, Riikka
    Borsi, Andras
    Koivunen, Minni
    Tillonen, Jyrki
    Sipponen, Taina
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 718 - 725
  • [6] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Rullan, M.
    Elosua, A.
    Saldana, C.
    Amorena, E.
    Vicuna, M.
    Rubio, S.
    Nantes, O.
    Rodriguez, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S453 - S454
  • [7] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Sanchez Rodriguez, E.
    Mesonero Gismero, F.
    Lopez Sanroman, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S590 - S591
  • [8] Objectively assessed disease activity during ustekinumab treatment in a nationwide real-life Crohn's disease cohort
    Af Bjorkesten, C. G.
    Ilus, T.
    Hallinen, T.
    Soini, E.
    Eberl, A.
    Hakala, K.
    Heikura, M.
    Hirsi, E.
    Jussila, A.
    Kellokumpu, M.
    Koskela, R.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nieminen, U.
    Nuutinen, H.
    Heikkinen, M.
    Suhonen, U. M.
    Tillonen, J.
    Utriainen, K.
    Vihriala, I.
    Wennerstrom, C.
    Borsi, A.
    Nissinen, R.
    Koivunen, M.
    Sipponen, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S434 - S435
  • [9] Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
    Straatmijer, T.
    Biemans, V. B. C.
    Hoentjen, F.
    de Boer, N. K. H.
    Bodelier, A. G.
    Dijkstra, G.
    van Dop, W.
    Haans, J. J. L.
    Jansen, J. M.
    Maljaars, P. W. J.
    van der Marel, S.
    Oldenburg, B.
    Ponsioen, C. Y.
    Visschedijk, M. C.
    de Vries, A. C.
    West, R.
    van der Woudeu, C. J.
    Pierik, M.
    Duijvestein, M.
    van der Meulen-de Jong, A. E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S319 - S319
  • [10] Ustekinumab Use in Crohn's Disease: Real-Life Canadian Experience
    Greenup, Astrid-Jane
    Rosenfeld, Greg
    Bressler, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S334 - S335
12345